SightfileU.S. market data from official filings

AARDVARK THERAPEUTICS INC (AARD)

Name: AARDVARK THERAPEUTICS INC (AARD) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001774857 · EDGAR filings · Updated 2026-07-10

AARDVARK THERAPEUTICS INC (AARD) has reported institutional ownership of 46.8%, with 79 institutional managers holding positions valued at $38.5M per the latest 13F reporting period.

Institutional ownership

46.8%

Institutional managers

Reported 13F value

$38.5M

Insider activity

11 trans.

$450.3K net buying

Latest updates

2026-07-10 — ARS filed
2026-07-10 — Proxy statement (DEF 14A) filed
2026-06-29 — PRE 14A filed
2026-06-12 — Current report (8-K) filed
2026-05-14 — Current report (8-K) filed
2026-05-07 — Quarterly report (10-Q) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, AARDVARK THERAPEUTICS INC has 79 institutional holders and institutional ownership of 46.8%.

Insider activity

Insiders reported 11 transactions (8 buys, 0 sells) across 3 reporting insiders, with a net reported value of $450.3K.

Related companies

CANTON STRATEGIC HOLDINGS IN (CNTN) · AUNA S A (AUNA) · GALECTIN THERAPEUTICS (GALT) · ACTUATE THERAPEUTICS INC (ACTU) · TENAYA THERAPEUTICS INC (TNYA) · Cardiol Therapeutics Inc (CRDL)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-10.